Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $4.24M | ﹤0.01% |
25,000
-5,000
| -17% | -$732K |
|
|
JPUS
3427
JPMorgan Diversified Return US Equity ETF
JPUS
$463M
| $4.24M | ﹤0.01% |
43,795
| – | – |
|
3428
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
| $4.24M | ﹤0.01% |
44,342
| – | – |
|
3429
La-Z-Boy
LZB
$1.66B
| $4.23M | ﹤0.01% |
114,228
-24,198
| -17% | -$1.02M |
|
3430
Newmark Group
NMRK
$2.77B
| $4.22M | ﹤0.01% |
351,791
-122,789
| -26% | -$1.47M |
|
3431
CALL
Sunrun
RUN
$2.5B
| $4.22M | ﹤0.01% |
+75,700
| New | +$3.66M |
|
3432
Carpenter Technology
CRS
$28.3B
| $4.22M | ﹤0.01% |
104,975
+8,229
| +9% | +$348K |
|
3433
PUT
NovoCure
NVCR
$1.87B
| $4.21M | ﹤0.01% |
19,000
| – | – |
|
|
MRNS
3434
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.21M | ﹤0.01% |
234,872
+4,878
| +2% | +$78.5K |
|
|
LIV
3435
DELISTED
Emles @Home ETF
LIV
| $4.2M | ﹤0.01% |
150,000
| – | – |
|
3436
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
| $4.19M | ﹤0.01% |
32,135
-30,161
| -48% | -$3.94M |
|
3437
Collegium Pharmaceutical
COLL
$1.16B
| $4.19M | ﹤0.01% |
177,385
-12,612
| -7% | -$291K |
|
|
TMAC
3438
DELISTED
The Music Acquisition Corporation
TMAC
| $4.19M | ﹤0.01% |
433,378
+164,630
| +61% | +$1.61M |
|
3439
Manchester United
MANU
$3.84B
| $4.18M | ﹤0.01% |
275,411
+264,679
| +2,466% | +$4.25M |
|
3440
First Interstate BancSystem
FIBK
$3.63B
| $4.18M | ﹤0.01% |
99,963
+24,643
| +33% | +$1.14M |
|
3441
CALL
American International
AIG
$42.1B
| $4.18M | ﹤0.01% |
+87,800
| New | +$4.34M |
|
3442
Theravance Biopharma
TBPH
$876M
| $4.18M | ﹤0.01% |
287,759
+6,639
| +2% | +$125K |
|
3443
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $4.18M | ﹤0.01% |
117,825
+25,361
| +27% | +$960K |
|
3444
Vaxcyte
PCVX
$8.07B
| $4.18M | ﹤0.01% |
185,585
+4,485
| +2% | +$91.8K |
|
3445
CrossAmerica Partners
CAPL
$810M
| $4.17M | ﹤0.01% |
219,039
-10,480
| -5% | -$206K |
|
3446
State Street SPDR Portfolio TIPS ETF
SPIP
$1B
| $4.17M | ﹤0.01% |
134,049
-21,818
| -14% | -$674K |
|
|
WSR
3447
DELISTED
Whitestone REIT
WSR
| $4.17M | ﹤0.01% |
505,818
+225,264
| +80% | +$2.02M |
|
|
DENN
3448
DELISTED
Denny's
DENN
| $4.16M | ﹤0.01% |
252,369
+8,591
| +4% | +$150K |
|
3449
Gossamer Bio
GOSS
$86.9M
| $4.15M | ﹤0.01% |
511,575
-465,522
| -48% | -$4.04M |
|
3450
PUT
AstraZeneca
AZN
$250B
| $4.15M | ﹤0.01% |
+34,650
| New | +$3.8M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 820 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 820 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.